Belgium-based Complix Raises €5 Million
Complix NV, a Belgium-based developer of "alphabodies" for autoimmune and infectious diseases, has raised €5 million in Series A funding. Backers include Vesalius Biocapital, LRM and CRP Santé.
9 June 2010•1 min read
